GENETICALLY REPROGRAMMED MYCOPLASMA BACTERIA AND USES THEREOF

摘要

The present invention concerns oligonucleotide arrangements that express gene products having an anti- biofilm activity, and bacteria comprising said oligonucleotide arrangements. Also intended is the use of such arrangements and bacteria as a medicament. Further intended are pharmaceutical compositions comprising genetically modified (e.g. attenuated) Mycoplasma bacteria.